Pirimed

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pirimed

Quick Facts

Property Description
Active Ingredient Pyrithione Zinc (ZnP)
Form Topical Treatment (Shampoo, Cream, Lotion)
Pharmacological Class Antifungal Agent, Dermatological Agent
Common Use Management of microbial imbalance on skin and scalp
Origin Synthetic Coordination Complex

What Type of Medicine Is Pirimed, and What Is Its Composition?

Pirimed is a pharmaceutical preparation classified as a dermatological agent that contains the active ingredient Pyrithione Zinc (or ZnP). This compound belongs to the Antifungal agent and Miscellaneous topical agent pharmacological classes. Chemically, Pyrithione Zinc is a Synthetic coordination complex of the zinc cation, distinguished from simple zinc salts, with the formula C10H8N2O2S2Zn. This active agent is characterized by its strong fungistatic and bacteriostatic actions.

Pirimed’s Delivery Method and Classification

The medicine is strictly designed as a Topical treatment for External use only. The product is typically formulated as a Single active ingredient preparation in forms such as Shampoo, Cream, or Lotion. Its formulation capitalizes on the low solubility of Pyrithione Zinc to ensure the active material is deposited and retained effectively on the skin surface. The preparation is classified as an Over-the-counter (OTC) drug in the United States for external health management.

What Is the General Purpose of Pyrithione Zinc?

The general purpose of Pirimed is to manage microbial imbalance associated with common scalp conditions through its inherent fungistatic property. The agent works by inhibiting the growth and proliferation of problematic microorganisms, notably the Malassezia fungus. This antifungal action is mediated by the compound increasing cellular copper levels, which damages proteins essential for fungal metabolism. By controlling microbial overgrowth and regulating the shedding of epidermal cells, the agent’s principal benefit is to help mitigate flaking and irritation of the skin and scalp.

What side effects are possible with Pirimed?

Possible Side Effects and Safety Information

The safety profile of Pirimed, which contains Pyrithione Zinc, is defined by regulatory documents focusing on local effects consistent with its use as a strictly topical treatment. The adverse reactions are primarily classified within Skin and Subcutaneous Tissue Disorders.

Category Description
Frequency Classification Documented reactions are generally classified as less common or rare in regulatory summaries.
Common Adverse Reactions These include localized skin irritation, stinging or burning of the scalp, and skin peeling.
Serious Adverse Reactions The potential for rare, severe allergic reactions is noted, which may manifest as rash, hives, swelling of the face, mouth, or throat, or difficulty breathing.
Safety Restrictions The medicine is strictly for external use only, and contact with the eyes must be avoided, as this is a safety constraint mandated in the official labeling.

Population-Specific Safety Considerations

Official patient information summaries indicate that the agent is not expected to cause different side effects in either the pediatric or older adult populations than in younger adults. No known drug interactions are listed for the topical form of Pyrithione Zinc in authoritative government references.

Regulatory Safety Summary

The most significant safety constraint is the external use only restriction, which limits exposure and consequently confines the documented adverse reactions to the site of application. This localization of effects, coupled with the less common or rare frequency classification for irritation, defines the low overall topical risk profile as documented by regulatory bodies.

Overdose and Emergency Response

Pirimed Overdose and when to seek help

An overdose of Pirimed, which contains the active ingredient pirfenidone, can lead to increased severity of the drug’s known adverse effects. Since pirfenidone is primarily indicated for idiopathic pulmonary fibrosis, an overdose requires immediate medical attention due to the potential for significant organ impact.

Overdose symptoms may include, but are not limited to, severe forms of common side effects such as nausea, vomiting, diarrhea, and abdominal pain. More serious signs could involve marked central nervous system effects or severe dermatological reactions.

System/Area Potential Symptoms of Severe Overdose
Gastrointestinal Severe nausea, protracted vomiting, acute diarrhea, severe abdominal pain
Dermatologic Severe rash, exaggerated photosensitivity reaction
Neurologic Confusion, significant drowsiness or lethargy

When to Seek Emergency Help

An overdose of Pirimed is considered a medical emergency. You must seek immediate professional help if you or someone else has taken more than the prescribed amount. Do not wait for symptoms to appear. The long-term effects of an overdose, particularly on the liver and kidneys, may not be immediately apparent.

Call your local emergency number or Poison Control Center immediately if you suspect an overdose. Be prepared to provide the name of the medicine, the amount taken, and the time it was consumed. Follow the guidance provided by the emergency medical professional.

Therapeutic Uses of Pirimed

What Pirimed Treats: Main Uses and Benefits

Pirimed is commonly used across conditions presenting with recurrent or episodic manifestations, notably common dandruff (Pityriasis capitis) and seborrheic dermatitis. Its use is generally considered relevant for addressing symptoms that interfere with daily functioning associated with these recurrent scalp and skin disorders. The medication is applied across therapeutic domains where additional symptomatic support is needed, primarily to address symptoms related to flaking and scaling, persistent itching (pruritus), and associated irritation.

It may assist with managing symptoms that interfere with daily comfort, such as those linked to recurrent manifestations and the associated oiliness. When groups of symptoms intensify temporarily, Pirimed can assist with maintaining functional stability by easing the overall symptom load. The core benefit is providing support that helps ease the overall symptom burden, as the medication is relevant for symptomatic relief in these chronic situations.


Quick Fact: Relief for Flaking

Property Description
Primary Indication Dandruff (Pityriasis capitis), Seborrheic Dermatitis
Key Symptoms Addressed Flaking, Scaling, Persistent Itching, Irritation
General Benefit Contributes to improved comfort, eases overall symptom load
Usage Context Management of recurrent or episodic manifestations

Regulatory References

  1. NIH DailyMed platform

Eligibility and Restrictions for Use

Who can and cannot use Pirimed? (Pyrithione Zinc)

The population eligibility rules for Pirimed are defined by specific criteria established in official regulatory documents, primarily focusing on age, physiological status, and known hypersensitivity.

Contraindications and Absolute Restrictions

Pirimed is contraindicated in individuals with a known allergy or hypersensitivity to Pyrithione Zinc or any other inactive component present in the specific formulation. Individuals with this history must not use the product.

Eligibility by Age and Physiological Status

Use is generally accepted for adults and children over two years of age for the labeled topical uses. However, use is restricted in the youngest population:

  • Children under 2 years of age must not use this medicine unless its use and dosage have been determined and directed by a physician.

  • Pregnant or breastfeeding individuals must consult a healthcare professional before use, establishing conditional eligibility for these populations.

Other Use Limitations

The medicine is strictly intended for External Use Only. Additionally, a professional must be consulted prior to use if the skin condition covers a large area of the body.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Pirimed is based on its formulation as a topical dermatological agent containing Pyrithione Zinc. A key factor governing its interaction potential is the negligible amount of the active ingredient that is absorbed into the systemic circulation following external use. This low systemic exposure profile is consistently reflected in regulatory documentation, such as the relevant Antidandruff Drug Product monographs in the United States and similar regulatory conclusions worldwide.

Documented Systemic Interaction Status

Due to the minimal systemic availability of Pyrithione Zinc, authoritative government regulatory documents, including those from the U.S. Food and Drug Administration (FDA), typically do not list specific systemic drug-drug interactions.

Interaction Type Regulatory Finding
Pharmacokinetic Interactions No specific metabolic, enzyme-mediated (CYP), or transporter-mediated interactions are officially documented for systemic co-administered drugs.
Pharmacodynamic Interactions No additive or synergistic effects with other systemic medications are noted in the regulatory labeling.

Constraints and Administration Requirements

Because Pirimed is not associated with sufficient systemic exposure to warrant interaction warnings, the labeling does not include:

  • Formal Contraindications: There are no specific medicinal products or product classes formally listed as being systemically contraindicated with Pirimed.
  • Timing Rules: No mandatory dose separation requirements or specific administration timing rules are required for co-administration with other medicines or ingested substances.
  • Food, Alcohol, or Supplements: Regulatory data does not document established interactions with food, alcohol, herbal products, or dietary supplements.

The constraints for use remain tied to the product's classification as for external use only, which limits the potential for systemic interaction risk.

Mechanism of Action

Molecular Blockade of Prostanoid Synthesis

Pirimed functions as a non-selective competitive inhibitor of the Cyclooxygenase (COX) enzymes (COX-1 and COX-2), key components of the Arachidonic Acid Cascade. This molecular blockade prevents the COX enzymes from catalyzing the synthesis of prostanoids, which are local lipid mediators such as prostaglandins and thromboxanes. This mechanism interrupts the primary signaling pathway for the generation of pro-inflammatory and pyretic mediators.

Modulation of Nociceptor and Thermoregulatory Signaling

The mechanistic action involves both peripheral activity at sites of elevated COX-2 expression and central action within the brain's hypothalamus. By reducing local prostaglandin production, Pirimed limits the prostaglandin-mediated sensitization of peripheral nociceptors and causes the downward adjustment of the body's thermoregulatory set-point. This dual effect modulates physiological processes resulting from prostaglandin synthesis, leading to a reduction in prostaglandin-mediated nociceptor activation and alteration of the hypothalamic temperature set-point.

Dosage and Administration Information

How to Use Pirimed: Administration Guidelines

Pirimed (Pyrithione Zinc) is formulated for Topical use only and is strictly designated for External Use Only. The administration of this dermatological agent is determined by its dosage form, which most commonly is a 1% or 2% shampoo concentration.


Application Procedure and Frequency

The standard application involves a specific pattern and schedule to ensure delivery of the active ingredient:

Instruction Domain Requirement (Shampoo Formulation)
Preparation Shake well before use (for suspension products).
Application Wet hair; apply a liberal amount to the scalp and work into a lather.
Contact Time Massage into the scalp and leave the lather on for several minutes before rinsing.
Rinsing Rinse hair and scalp thoroughly after application; repeating the application is optional.

For best results, Pirimed shampoo should be used at least twice a week. The regimen may involve use every time hair is shampooed for maximum control, or it may be used as a part of a sustained plan until the condition improves. If symptoms do not improve after regular use as directed, the use of the product should be discontinued.


Population-Specific Rules

As a standard precaution, the product is not recommended for use in children under 2 years of age, unless use is specifically directed by a healthcare provider.

Recent Clinical Evidence

Pirimed: Recent Clinical Evidence

Research on Pirimed and Pain Management

Clinical research has examined the study results related to Pirimed in managing both chronic and acute pain. Studies investigated the symptom measurements documented over the treatment period.

A key study documented changes in pain levels and compared the findings to results associated with other compounds. Adverse events were recorded among study participants across various populations. Trial protocols generally excluded the use of alcohol during treatment or monitored for potential interactions.


Combination Therapy

Research evaluated the findings related to the combination of Pirimed and Drug Z in relation to changes in patient mobility. Adverse events were recorded among participants in these combination studies.

Further research is exploring the role of Pirimed in current pain management strategies, and whether its use was evaluated in relation to opioid dependence.


Use in Headaches and Specific Populations

Studies investigated the potential for Pirimed in treating headaches, specifically documenting the symptom measurements over the study period. The trials measured results in both tension-type and migraine headaches.

Participants with pre-existing liver conditions were often excluded from trials, or outcomes were specifically monitored in this subgroup. Findings related to its use in pediatric populations were mixed, and research in this area remains ongoing.

Frequently Asked Questions (FAQ)

Common questions about Pirimed (FAQ)


Q: What does it mean that Pirimed is a 'schedule X' medicine?

Pirimed (Pyrithione Zinc) is classified by regulatory authorities in the United States as a Human Over-the-Counter (OTC) Drug. This means it is widely available without a prescription and has no DEA schedule assigned, indicating it is not classified as a controlled substance.


Q: Can I take over-the-counter pain relievers while using Pirimed?

Authoritative documents note that Pirimed has no known systemic drug interactions listed with other medicines, including over-the-counter pain relievers. This is because Pirimed is strictly a topical treatment and minimal active ingredient is absorbed into the bloodstream.


Q: Is Pirimed considered safe for older adults (seniors)?

Official product information indicates that this medicine is not expected to cause different side effects or problems in older adults (seniors) compared to younger adults. The lack of expected differences is consistent with its topical use classification.


Q: What happens if a dose of Pirimed is forgotten?

Patient instructions described in official documents address forgotten doses by stating the dose may be applied when remembered. If it is near the time for the next scheduled application, the instructions describe skipping the forgotten dose and returning to the regular schedule.


Q: Can Pirimed affect my ability to drive or operate machinery?

Due to its topical-only route of administration and minimal absorption into the body, Pirimed is not associated with central nervous system (CNS) effects. Therefore, it is not expected to impair alertness or the safe use of machinery.


Q: What types of drug-drug interactions are listed in official documents for Pirimed?

Regulatory documents consistently state that Pirimed (Pyrithione Zinc) in its topical form has no known severe, serious, moderate, or mild systemic interactions with other medicines. This low-risk profile is due to the drug’s minimal systemic availability.


Q: Is it true that Pirimed can interact with certain common foods or drinks?

Regulatory data does not document established interactions with food, alcohol, or tobacco for topical Pirimed. The product is for external use, and systemic exposure is minimal.


Q: Why is Pirimed sometimes prescribed for more than one condition?

Official labeling confirms Pirimed is indicated for helping to prevent the recurrence of itching and flaking associated with both dandruff and seborrheic dermatitis. Both conditions involve the control of microbial imbalance on the skin and scalp.


Q: Does Pirimed have a risk of dependence or withdrawal symptoms?

Pirimed (Pyrithione Zinc) is classified as an Antifungal and Dermatological Agent and is not a controlled substance. As such, it is not associated with drug classes that typically carry risks of physical dependence or withdrawal symptoms.


Q: Is Pirimed considered a long-term treatment or short-term?

Official administration instructions recommend using the product at least twice a week and continuing use until the condition improves. This suggests the product is intended for a sustained treatment regimen or ongoing maintenance, rather than a single short course. The administration guidelines describe a sustained treatment regimen.


Q: Can taking Pirimed affect the results of blood tests?

Due to its classification as a topical agent with minimal systemic absorption, Pirimed is not expected to affect the results of common blood tests.


Q: Are there specific official guidelines about alcohol consumption while on Pirimed?

Regulatory data does not document established interactions with alcohol for topical Pirimed. Alcohol consumption is not restricted or discouraged based on the drug's official labeling.


Q: Is there a risk of developing a serious skin reaction while taking Pirimed?

Official warnings note the potential for rare, severe allergic reactions. Official warnings describe stopping the use of the product and consulting a professional if signs of an allergic reaction, such as a rash, hives, or swelling, are observed.


Q: What if I have an existing heart condition; is Pirimed still an option?

Pirimed is a topical agent with minimal absorption into the bloodstream. For this reason, official documents do not list heart conditions as a systemic contraindication or a necessary precaution.


Q: Do I need to take Pirimed at a specific time of day?

Official administration instructions require use at least twice a week but do not specify a mandatory time of day (e.g., morning or evening) for the application. It can be used whenever hair is shampooed.


Q: Why is close medical supervision sometimes mentioned when starting Pirimed?

The official label advises users to Ask a physician before use if the condition covers a large area of the body. This suggests professional guidance may be needed for widespread or severe conditions.


Q: Are there documented interactions between Pirimed and herbal products?

Regulatory data does not document established interactions with herbal products or dietary supplements for topical Pirimed. This is due to the minimal absorption of the active ingredient into the body.


Q: Why do some patients stop taking Pirimed?

The official warning label states to Stop use and ask a doctor if the condition worsens or does not improve after regular use as directed. This is a common regulatory reason for discontinuing use.


Q: Why is Pirimed only available by prescription?

Official regulatory documents classify Pirimed (Pyrithione Zinc) as a HUMAN OTC DRUG (Over-The-Counter Drug) in the United States. Therefore, it is widely available without a prescription.


Q: Does taking Pirimed make me sensitive to sunlight?

Review of the official side effects and warnings listed in regulatory documents does not indicate a known risk of photosensitivity (sun sensitivity) for Pirimed.


Q: Is Pirimed used globally for the same purposes?

International regulatory documents confirm that the active ingredient, Pyrithione Zinc, is widely approved and used globally for the management of dandruff and seborrheic dermatitis.


Q: Are there any known interactions between Pirimed and common cold medicines?

Authoritative documents state that Pirimed has no known systemic interactions with other medicines, including common OTC cold preparations. This is due to its low systemic absorption following topical application.


Q: Is there a known antidote if too much Pirimed is taken?

Official warnings state that if the medicine is swallowed, the immediate action described is to get medical help or contact a Poison Control Center. The labeling does not specify a known antidote for oral ingestion, indicating supportive care is required.


Q: Do people feel better immediately after starting Pirimed?

The product is designed to be used at least twice a week and until the condition improves. Official information indicates that the intended reduction of flaking and itching is a gradual process that requires consistent application.


Q: What is the typical time frame to see the expected effect of Pirimed?

Official guidelines advise that if the condition does not improve after regular use as directed, the user should stop use. This implies an expected improvement should be observed within a reasonable period of consistent application.


Q: Are there generic versions of Pirimed available?

Yes, many generic equivalent topical products containing the active ingredient Pyrithione Zinc are widely available, as noted in authoritative resources. The availability is consistent with its classification as an Over-the-Counter drug.


Q: Are there any specific safety warnings listed for Pirimed?

Key warnings listed in the official labeling include: For external use only, Avoid contact with eyes, and instructions to Stop use if condition worsens or does not improve.


Q: Does Pirimed require any special monitoring while being used?

As a topical treatment with minimal systemic absorption, official labeling does not require routine special monitoring of internal functions, such as blood work, while the product is being used.


Q: Can Pirimed cause weight changes?

Official side effect listings focus on localized effects at the application site. Systemic side effects like weight changes are not listed in the regulatory documents, consistent with the minimal absorption of the active ingredient.


Q: Does Pirimed affect mental alertness?

Due to its topical use only and minimal absorption into the body, Pirimed is not associated with effects on mental alertness in the official product labeling.


Q: What does the patient leaflet say about Pirimed's effectiveness?

Patient materials describe the product’s purpose as helping to prevent recurrence of flaking and itching associated with dandruff and seborrheic dermatitis. This is the official statement regarding the product's intended action.

How should Pirimed be stored and disposed of?

Official Storage and Disposal Requirements

Pirimed, a topical Pyrithione Zinc product, must be stored according to official regulatory specifications to maintain stability and ensure safety.

Storage Conditions

Requirement Specification (As per Regulatory Labeling)
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Protect from freezing and avoid excessive heat.
Container Keep the container tightly closed when not in use.

Safety and Disposal

The product must be stored out of reach of children. If the medicine is swallowed, immediate contact with a Poison Control Center is required. Unused or expired Pirimed must be disposed of according to applicable local regulations or designated drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pirimed found in:

A-Z Index: